SMTL ID : 2rfs.1

X-ray structure of SU11274 bound to c-Met

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x AM8: N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide(Non-covalent)

AM8.1: 16 residues within 4Å: Chain A: I.38, G.39, V.46, A.62, L.94, L.111, P.112, Y.113, M.114, K.115, G.117, M.165, A.175, D.176, A.180, Y.184 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.94, A:L.94, A:L.111, A:L.111, A:Y.184 Hydrogen bonds: A:M.114, A:M.114, A:D.176 pi-Stacking: A:Y.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bellon, S.F. et al., c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J.Biol.Chem. (2008)

Release Date

2007-11-06

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence